Soleus Capital Management as of March 31, 2023
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 77 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr Ser Tr S&p Biotech Call Option (XBI) | 16.4 | $159M | 2.1M | 76.21 | |
Edap Tms S A Sponsored Adr (EDAP) | 6.1 | $59M | 5.3M | 11.07 | |
Iveric Bio | 5.4 | $52M | 2.1M | 24.33 | |
Arcellx Common Stock (ACLX) | 4.0 | $39M | 1.2M | 30.81 | |
Charles River Laboratories (CRL) | 3.3 | $32M | 156k | 201.82 | |
EXACT Sciences Corporation (EXAS) | 3.2 | $31M | 457k | 67.81 | |
United Therapeutics Corporation (UTHR) | 3.2 | $31M | 136k | 223.96 | |
Iradimed (IRMD) | 3.2 | $30M | 774k | 39.35 | |
Smith & Nephew Spdn Adr New (SNN) | 2.8 | $27M | 970k | 27.91 | |
Organogenesis Hldgs (ORGO) | 2.2 | $21M | 9.9M | 2.13 | |
Si-bone (SIBN) | 2.2 | $21M | 1.1M | 19.67 | |
SurModics (SRDX) | 2.1 | $20M | 893k | 22.78 | |
CVS Caremark Corporation (CVS) | 1.9 | $18M | 244k | 74.31 | |
Celcuity (CELC) | 1.8 | $17M | 1.7M | 10.25 | |
Rigel Pharmaceuticals Com New | 1.8 | $17M | 13M | 1.32 | |
Axogen (AXGN) | 1.7 | $17M | 1.8M | 9.45 | |
Natera (NTRA) | 1.7 | $16M | 294k | 55.52 | |
Reata Pharmaceuticals Cl A | 1.6 | $16M | 175k | 90.92 | |
Seagen | 1.5 | $14M | 71k | 202.47 | |
Vaxcyte (PCVX) | 1.5 | $14M | 380k | 37.48 | |
The Beauty Health Company Com Cl A (SKIN) | 1.4 | $14M | 1.1M | 12.63 | |
Jasper Therapeutics | 1.4 | $14M | 7.5M | 1.81 | |
Essa Pharma Com New (EPIX) | 1.3 | $12M | 4.1M | 2.97 | |
Bioatla (BCAB) | 1.2 | $12M | 4.3M | 2.68 | |
Humana (HUM) | 1.2 | $12M | 24k | 485.46 | |
Tg Therapeutics (TGTX) | 1.2 | $11M | 750k | 15.04 | |
Neuropace (NPCE) | 1.2 | $11M | 2.4M | 4.64 | |
Vericel (VCEL) | 1.0 | $9.6M | 326k | 29.32 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.0 | $9.4M | 114k | 82.56 | |
Iovance Biotherapeutics (IOVA) | 0.9 | $8.9M | 1.4M | 6.11 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.9 | $8.8M | 412k | 21.27 | |
Inhibrx | 0.9 | $8.3M | 438k | 18.87 | |
Tandem Diabetes Care Com New (TNDM) | 0.9 | $8.3M | 203k | 40.61 | |
4d Molecular Therapeutics In (FDMT) | 0.8 | $8.1M | 469k | 17.19 | |
Novocure Ord Shs (NVCR) | 0.8 | $7.8M | 130k | 60.14 | |
Viking Therapeutics (VKTX) | 0.8 | $7.7M | 460k | 16.65 | |
89bio (ETNB) | 0.8 | $7.5M | 494k | 15.23 | |
C4 Therapeutics Com Stk (CCCC) | 0.8 | $7.5M | 2.4M | 3.14 | |
Theratechnologies | 0.8 | $7.4M | 9.1M | 0.81 | |
Krystal Biotech (KRYS) | 0.7 | $6.8M | 85k | 80.06 | |
Syndax Pharmaceuticals (SNDX) | 0.7 | $6.8M | 323k | 21.12 | |
Genedx Holdings Corp Com Cl A | 0.7 | $6.5M | 18M | 0.36 | |
Alkermes SHS (ALKS) | 0.7 | $6.5M | 230k | 28.19 | |
Inari Medical Ord (NARI) | 0.6 | $6.3M | 102k | 61.74 | |
Nuvalent Inc-a (NUVL) | 0.6 | $6.2M | 237k | 26.09 | |
Karuna Therapeutics Ord | 0.6 | $6.1M | 34k | 181.64 | |
Bridgebio Pharma (BBIO) | 0.6 | $6.0M | 364k | 16.58 | |
Mirum Pharmaceuticals (MIRM) | 0.6 | $5.8M | 242k | 24.02 | |
Travere Therapeutics (TVTX) | 0.5 | $5.3M | 235k | 22.49 | |
Keros Therapeutics (KROS) | 0.5 | $5.2M | 122k | 42.70 | |
Dice Therapeutics | 0.5 | $5.0M | 173k | 28.65 | |
Enanta Pharmaceuticals (ENTA) | 0.5 | $4.7M | 117k | 40.44 | |
Mineralys Therapeutics (MLYS) | 0.4 | $4.3M | 273k | 15.66 | |
Pieris Pharmaceuticals | 0.4 | $4.0M | 4.1M | 0.98 | |
Cerevel Therapeutics Hldng I (CERE) | 0.4 | $3.8M | 155k | 24.39 | |
Abcam Ads | 0.4 | $3.8M | 280k | 13.46 | |
Inspire Med Sys (INSP) | 0.4 | $3.7M | 16k | 234.07 | |
ACADIA Pharmaceuticals (ACAD) | 0.4 | $3.6M | 190k | 18.82 | |
Annexon (ANNX) | 0.4 | $3.5M | 915k | 3.85 | |
Paragon 28 (FNA) | 0.4 | $3.5M | 204k | 17.07 | |
Pharvaris N V (PHVS) | 0.3 | $2.7M | 337k | 8.05 | |
Fibrogen (FGEN) | 0.3 | $2.4M | 130k | 18.66 | |
AngioDynamics (ANGO) | 0.2 | $2.3M | 225k | 10.34 | |
Aclaris Therapeutics (ACRS) | 0.2 | $2.0M | 249k | 8.09 | |
Cardiovascular Systems | 0.2 | $1.9M | 95k | 19.86 | |
Amylyx Pharmaceuticals (AMLX) | 0.2 | $1.9M | 63k | 29.34 | |
Pardes Biosciences | 0.2 | $1.7M | 1.3M | 1.32 | |
Transmedics Group (TMDX) | 0.1 | $1.4M | 19k | 75.73 | |
Rxsight (RXST) | 0.1 | $1.3M | 80k | 16.68 | |
Axsome Therapeutics (AXSM) | 0.1 | $1.3M | 21k | 61.68 | |
Lyra Therapeutics (LYRA) | 0.1 | $1.2M | 592k | 2.01 | |
Health Sciences Acq Corp 2 (OBIO) | 0.1 | $1.2M | 61k | 19.57 | |
Pulmonx Corp (LUNG) | 0.1 | $794k | 71k | 11.18 | |
Xilio Therapeutics (XLO) | 0.1 | $719k | 227k | 3.17 | |
Immunic (IMUX) | 0.0 | $447k | 300k | 1.49 | |
Y Mabs Therapeutics (YMAB) | 0.0 | $437k | 87k | 5.01 | |
Mdxhealth Sa Sponsored Ads | 0.0 | $194k | 60k | 3.24 |